MoneyWorks4Me

Shilpa Medicare informs about revised disclosure

27 Sep 2024 Evaluate
Shilpa Medicare has informed that it enclosed the revised Disclosures of reasons for encumbrance by promoter of listed companies under Regulation 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on September 26, 2024 for Ramakant Innani.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..